Literature DB >> 8387964

Re: S. Iwarson: new vaccines against hepatitis A enter the market--but who should be vaccinated? (Infection 20 [1992] 192-193)

R Orlando, G Tosone, S Nappa, M Piazza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8387964     DOI： 10.1007/bf01710751

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  New vaccines against hepatitis A enter the market--but who should be vaccinated?

Authors:  S Iwarson
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

2.  Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy.

Authors:  T Stroffolini; M Chiaramonte; E Franco; M Rapicetta; D De Mattia; I Mura; R Trivello; A Giammanco; G Rigo; B Scarpa
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

3.  A prospective study of viral hepatitis A and the question of chronicity.

Authors:  G Lesnicar
Journal:  Hepatogastroenterology       Date:  1988-04

4.  Acute B viral hepatitis becomes fulminant after infection with hepatitis A virus.

Authors:  M Piazza; V Guadagnino; R Orlando; L Picciotto
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-26

5.  Relapsing viral hepatitis type A.

Authors:  I M Jacobson; B J Nath; J L Dienstag
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

6.  Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.

Authors:  I V Weller; P Karayiannis; A S Lok; L Montano; M Bamber; H C Thomas; S Sherlock
Journal:  Gut       Date:  1983-11       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.